Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 1002-1011
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.1002
Table 2 Comparison of length of hospital stay, clinical outcomes, hospital charges, and drug use between the non-pathway and clinical pathway groups
CharacteristicNon-pathway group (n = 467)Cinical pathway group (n = 2196)P value
Length of total hospital stay (median, range)8 (6-11)7 (5-9)< 0.001a
Pre-operative length of stay2 (1-4)2 (1-3)0.451
Readmission, n (%)34 (7.28)173 (7.88)0.661
Clinical outcomes, n (%)0.115
Recovered223 (47.75)1146 (52.19)
Improved236 (50.54)1028 (46.81)
Not improved8 (1.71)22 (1)
Died00
Charges of hospitalization (CNY), (median, range) n = 467/218321508.3 (17150.6-30045.8)18362.9 (15665.8-22895.2)< 0.001a
Charges of medication, n = 459/21536620.6 (3429.4-12239.7)4900.6 (3172.4-8186.0)< 0.001a
Charges of operation, n = 458/21515741.0 (4519.2-7324.0)5455.2 (2670.0-6964.0)< 0.001a
Charges of nursing, n = 454/2133188.0 (115.0-288.0)120.0 (74.0-211.0)< 0.001a
Charges of materials, n = 409/15407916.4 (6696.0-10552.6)6985.5 (6135.1-8224.7)< 0.001a
Charges of examination, n = 459/21532698.0 (2224.5-3799.5)2463.5 (2134.5-3105.5)< 0.001a
Antibiotic use, n (%)260/430 (60.47)832/1737 (47.90)< 0.001a
Antibiotic usage duration (d) (median, range), n = 260/83212 (8.0-18.5)11 (7.0-17.0)0.004a
Three line antibiotic use, n (%)51/430 (11.86)149/1737 (8.58)0.035a
Secondary surgery, n (%)69 (14.78)372 (16.94)0.253